Onconova Therapeutics Announces Presentations at Three Upcoming Conferences
May 28, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 28, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial Results
May 14, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...
Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China
May 13, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
Onconova to Receive $4 Million Upfront, including $2 Million Fee and $2 Million for Onconova Shares Purchased at a Premium, Plus up to $45.5 Million in Regulatory and Sales Milestones for Rigosertib...
Onconova Therapeutics Announces Presentations at the 15th International Symposium on Myelodysplastic Syndromes (MDS 2019) in Copenhagen, Denmark
May 06, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 06, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...
Onconova Therapeutics to Present Update at the 2019 HCW Global Life Sciences Conference in London, April 7-9
April 02, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. Reports Business Highlights and Full Year 2018 Financial Results
March 26, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., March 26, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...
Inspire’s Health Profiles Identifies the Insights of Patients to Unlock Research Gaps
December 13, 2018 08:00 ET
|
Inspire
ARLINGTON, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Inspire, the leading healthcare social network for patients and caregivers, is offering new opportunities for academic research partners to...
Inspire and Antidote Launch End-to-End Clinical Trial Recruitment Solution to Accelerate Medical Research
January 04, 2018 07:00 ET
|
Inspire
ARLINGTON, Va. and NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Inspire, the leading healthcare social network, and Antidote, a digital health company that connects patients with research, announced...
The World’s First Smart Book Scanner Involves A Life and Death Story
December 21, 2017 10:00 ET
|
CZUR
SHENZHEN, China, Dec. 21, 2017 (GLOBE NEWSWIRE) -- CZUR TECH CO., LTD. recently launched an upgraded smart book scanner, ET16 Plus, and has quickly received a good response. Being a professional...
Mega Construx™ to Deliver Powerful Message on Unity
April 11, 2017 08:00 ET
|
Mattel Canada Inc.
TORONTO, April 11, 2017 (GLOBE NEWSWIRE) -- Mega Construx™ is inviting children from across Canada to come together and join them in constructing a giant monument that celebrates diversity, unity...